A prospective, observational study of fidaxomicin use for Clostridioides difficile infection in France.

MLA

Guery, Benoit, et al. “A Prospective, Observational Study of Fidaxomicin Use for Clostridioides Difficile Infection in France.” Journal of International Medical Research, vol. 49, no. 6, June 2021, pp. 1–16. EBSCOhost, https://doi.org/10.1177/03000605211021278.

APA

Guery, B., Berger, P., Gauzit, R., Gourdon, M., Barbut, F., DAFNE study group:, Bémer, P., Bessède, E., Camou, F., Cattoir, V., Couzigou, C., Descamps, D., Dinh, A., Laurans, C., Lavigne, J.-P., Lechiche, C., Leflon-Guibout, V., Le Monnier, A., Levast, M., & Mootien, J. Y. (2021). A prospective, observational study of fidaxomicin use for Clostridioides difficile infection in France. Journal of International Medical Research, 49(6), 1–16. https://doi.org/10.1177/03000605211021278

Chicago

Guery, Benoit, Pierre Berger, Remy Gauzit, Magali Gourdon, Frédéric Barbut, DAFNE study group:, Pascale Bémer, et al. 2021. “A Prospective, Observational Study of Fidaxomicin Use for Clostridioides Difficile Infection in France.” Journal of International Medical Research 49 (6): 1–16. doi:10.1177/03000605211021278.